Condition: Tricuspid Regurgitation (TR) · Sponsor: Tau-MEDICAL Co., Ltd.
This clinical trial aims to evaluate the safety and demonstrate the efficacy of treatment to improve tricuspid regurgitation (TR) symptoms in patients with severe and clinically symptomatic TR through long-term implantation of an investigational medical device. 1. Determine the safety of long-term implantation of the investigational medical device "Pivot Extend" by monitoring for MACEs associated with the investigational medical device or procedure that may occur with long-term associated with the investigational medical device or procedure that may occur with long-term implantation. 2. Device success, procedural success, and clinical outcomes of long-term implantation of the investigational medical device "Pivot Extend" will be monitored.
This description comes directly from the study's public registry record.
Markus Reinthaler, MD, PhD · +49 (0) 157 37972007 · reinthal@gmail.com
Seung-Whan Lee, MD, PhD · +82 1688-7575 · seungwlee@amc.seoul.kr
Always discuss trial participation with your own doctor first.
| Israeli-Georgian Medical Research Clinic Healthycore | Tbilisi, K'alak'i T'bilisi, Georgia | Recruiting |
| Tbilisi Heart and Vascular Clinic | Tbilisi, K'alak'i T'bilisi, Georgia | Recruiting |
| Tbilisi Heart Center | Tbilisi, K'alak'i T'bilisi, Georgia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06877520